CRISPR-Cas: biology, mechanisms and relevance.
Hille F, Charpentier E. · 2016
Read CRISPR-Cas: biology, mechanisms and relevance. by Hille F, Charpentier E. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5052741.txt.
Introduction
Frank Hille and Emmanuelle Charpentier review CRISPR-Cas in Philosophical Transactions of the Royal Society B in 2016. CRISPR is the adaptive immune system of bacteria and archaea: it stores snippets of past invaders' DNA and uses them as guides to cut matching invaders on their return. Charpentier is one of the system's pioneers, and the review sums up the field's major finds.
The authors walk through how spacers are captured, how guide RNAs are made, and how Cas proteins find and cut their targets. They also cover roles beyond defense that the system plays in bacterial life. The second half turns to human use. The stripped-down Cas9 system now edits DNA in a wide range of cells and organisms, with medical aims, and CRISPR parts are being shaped into antimicrobials that kill only chosen bacteria. Gaps in understanding the immunity steps are flagged for future work.
Catalog record
| CREATOR | Hille F, Charpentier E. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
CRISPR-Cas: biology, mechanisms and relevance By Frank Hille, Emmanuelle Charpentier Published in: Philosophical Transactions of the Royal Society B: Biological Sciences DOI: 10.1098/rstb.2015.0496 ABSTRACT Abstract Prokaryotes have evolved several defence mechanisms to protect themselves from viral predators. Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated proteins (Cas) display a prokaryotic adaptive immune system that memorizes previous infections by integrating short sequences of invading genomes—termed spacers—into the CRISPR locus. The spacers interspaced with repeats are expressed as small guide CRISPR RNAs (crRNAs) that are employed by Cas proteins to target invaders sequence-specifically upon a reoccurring infection. The ability of the minimal CRISPR-Cas9 system to target DNA sequences using programmable RNAs has opened new avenues in genome editing in a broad range of cells and organisms with high potential in therapeutical applications. While numerous scientific studies have shed light on the biochemical processes behind CRISPR-Cas systems, several aspects of the immunity steps, however, still lack sufficient understanding. This review summarizes major discoveries in the CRISPR-Cas field, discusses the role of CRISPR-Cas in prokaryotic immunity and other physiological properties, and describes applications of the system as a DNA editing technology and antimicrobial agent. This article is part of the themed issue ‘The new bacteriology’. Keywords: CRISPR, Cas9, bacteriophage, genome editing INTRODUCTION Being the most abundant entities on our planet, bacterial and archaeal viruses (bacteriophages or phages) display a constant threat to prokaryotic life. In order to withstand phages, prokaryotes have evolved several defence strategies. In the past decade, the prokaryotic immune system CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) caught increasing attention in the scientific community not only because of its unique adaptive nature, but also because of its therapeutic potential. This review seeks to summarize the major discoveries made in the field of CRISPR-Cas, and describes the biological roles of the system in antiviral defence and other biological pathways as well as its significance for medical application. CRISPR-Cas is the only adaptive immune system in prokaryotes known so far. In this system, small guide RNAs (crRNAs) are employed for sequence-specific interference with invading nucleic acids. CRISPR-Cas comprises a genomic locus called CRISPR that harbours short repetitive elements (repeats) separated by unique sequences (spacers), which can originate from mobile genetic elements (MGEs) such as bacteriophages, transposons or plasmids. The so-called CRISPR array is preceded by an AT-rich leader sequence and is usually flanked by a set of cas genes encoding the Cas proteins [1–4]. To date, CRISPR-Cas systems can be divided into two main classes, which are further classified into six types and several sub-types [5–7]. The classification is based on the occurrence of effector Cas proteins that convey immunity by cleaving foreign nucleic acids. In class 1 CRISPR-Cas systems (types I, III and IV), the effector module consists of a multi-protein complex whereas class 2 systems (types II, V and VI) use only one effector protein [5]. MOLECULAR MECHANISMS: ADAPTATION, MATURATION AND INTERFERENCE The CRISPR-Cas system acts in a sequence-specific manner by recognizing and cleaving foreign DNA or RNA. The defence mechanism can be divided into three stages: (i) adaptation or spacer acquisition, (ii) crRNA biogenesis, and (iii) target interference (figure 1). [Figure: Simplified model of the immunity mechanisms of class 1 and class 2 CRISPR-Cas systems. The CRISPR-Cas systems are composed of a cas operon (blue arrows) and a CRISPR array that comprises identical repeat sequences (black rectangles) that are interspersed by phage-derived spacers (coloured rectangles). Upon phage infection, a sequence of the invading DNA (protospacer) is incorporated into the CRISPR array by the Cas1–Cas2 complex. The CRISPR array is then transcribed into a long precursor CRISPR RNA (pre-crRNA), which is further processed by Cas6 in type I and III systems (processing in type I-C CRISPR-Cas systems by Cas5d). In type II CRISPR-Cas systems, crRNA maturation requires tracrRNA, RNase III and Cas9, whereas in type V-A systems Cpf1 alone is sufficient for crRNA maturation. In the interference state of type I systems, Cascade is guided by crRNA to bind the foreign DNA in a sequence-specific manner and subsequently recruits Cas3 that degrades the displaced strand through its 3′–5′ exonucleolytic activity. Type III-A and type III-B CRISPR-Cas systems employ Csm and Cmr complexes, respectively, for cleavage of DNA (red triangles) and its transcripts (black triangles). A ribonucleoprotein complex consisting of Cas9 and a tracrRNA : crRNA duplex targets and cleaves invading DNA in type II CRISPR-Cas systems. The crRNA-guided effector protein Cpf1 is responsible for target degradation in type V systems. Red triangles represent the cleavage sites of the interference machinery.] Adaptation (a). In a first phase, a distinct sequence of the invading MGE called a protospacer is incorporated into the CRISPR array yielding a new spacer. This event enables the host organism to memorize the intruder's genetic material and displays the adaptive nature of this immune system [1]. Two proteins, Cas1 and Cas2, seem to be ubiquitously involved in the spacer acquisition process as they can be found in almost all CRISPR-Cas types. Exceptions are the type III-C, III-D and IV CRISPR-Cas systems, which harbour no homologous proteins. Moreover, type V-C shows a minimal composition as it comprises only a putative effector protein termed C2C3 and a Cas1 homologue [5–7]. In past years, major advances have been made in revealing the biochemical and genetic principles of CRISPR-Cas immunity. However, the mechanism of spacer acquisition is still not fully understood [8,9]. The selection of protospacers and their processing before integration remain widely obscure in many CRISPR-Cas types. Recent findings, however, shed light on the biochemistry of the spacer integration process. It has been demonstrated that Cas1 and Cas2 of the type I-E system of Escherichia coli form a complex that promotes the integration of new spacers in a manner that is reminiscent of viral integrases and transposases [10–13]. Although both Cas1 and Cas2 are nucleases [14–16], the catalytically active site of Cas2 is dispensable for spacer acquisition [10–12]. A new spacer is usually incorporated at the leader-repeat boundary of the CRISPR array [1] while the first repeat of the array is duplicated [17,18]. The mechanisms of the different CRISPR-Cas types might be conserved only to a certain extent as several studies have shown variations regarding the requirements and targets of the adaptation machinery. While Cas1 and Cas2 are sufficient to promote spacer acquisition in most studied type I CRISPR-Cas systems, type I-B further requires Cas4 for adaptation [19]. The type I-F CRISPR-Cas system of Pseudomonas aeruginosa additionally requires the interference machinery to promote the uptake of new spacers [20]. Similarly, type II-A systems require Csn2, Cas9 and tracrRNA (trans activating CRISPR RNA—see further details below) for acquisition [1,21,22]. Another, so far unique, adaptation mode was revealed for a type III-B Cas1 protein that is fused to a reverse transcriptase. Here, acquisition from both DNA and RNA was reported [23]. The selection of a target sequence that is integrated into the CRISPR locus is not random. It has been demonstrated that in type I, II and V CRISPR-Cas systems, a short sequence, called the protospacer adjacent motif (PAM), is located directly next to the protospacer and is crucial for acquisition and interference [24–29]. In type II-A CRISPR-Cas systems, the PAM-recognizing domain of Cas9 is responsible for protospacer selection [21,22]. It is